January 03, 2014
Drug distributor American Sales Co. on Thursday hit Boehringer Ingelheim Pharmaceuticals Inc. and Teva Pharmaceuticals USA Inc. with a proposed class action over an alleged $120 million pay-for-delay deal, the latest in a spate of suits over agreements to keep generic medicines off the market.